Foundational Science and Mechanisms of Disease

Match each patient's clinical presentation with the primary mechanism of action of the responsible bacterial toxin.

Targeted biologic therapies are foundational in the management of severe rheumatologic, gastrointestinal, and dermatologic autoimmune diseases. The efficacy and safety profile of each agent are intrinsically linked to its specific immunopathologic target. Match each immunomodulating biologic agent with its precise molecular target in the inflammatory cascade.

A 32-year-old woman is brought to the emergency department by her husband due to agitation, confusion, and shivering. She has a history of major depressive disorder, for which she is maintained on citalopram. Three days ago, she visited an urgent care clinic for a severe respiratory infection and was prescribed linezolid. On physical examination, her temperature is $39.4^\circ\text{C}$ ($102.9^\circ\text{F}$), pulse is $122/\text{min}$, and blood pressure is $165/98 \text{ mm Hg}$. She is diaphoretic and exhibits ocular clonus and bilateral lower extremity hyperreflexia. Intravenous fluids and benzodiazepines are administered, but her symptoms persist. The physician decides to administer cyproheptadine as a targeted antidote. Which of the following best describes the expected pharmacodynamic effect of this antidote on the dose-response curve of the involved endogenous neurotransmitter?

A detailed understanding of cytokine networks and immune cell interactions is essential for recognizing the pathogenesis of various inflammatory, autoimmune, and infectious conditions, as well as for utilizing targeted biologic therapies. Match each clinical presentation or pathologic process with the primary cytokine or immunologic mechanism that directly drives its development.

Match each of the following clinical scenarios with the most accurate corresponding pharmacokinetic alteration expected in that patient.

A 52-year-old woman presents to the clinic complaining of severe fatigue, generalized joint aches, and a new rash on her lower extremities that appeared $3$ days ago. She has a history of intravenous drug use in her twenties but states she has been abstinent for over two decades. On physical examination, her temperature is $37.2^\circ\text{C}$ ($99.0^\circ\text{F}$), blood pressure is $145/90 \text{ mm Hg}$, and pulse is $82/\text{min}$. Examination of the legs reveals non-blanching, erythematous macules and papules that coalesce into plaques. Laboratory studies reveal the following:

Urinalysis shows $2+$ protein, $15-20$ red blood cells/hpf, and occasional red blood cell casts. Which of the following best describes the fundamental immunopathologic mechanism responsible for this patient's cutaneous and renal findings?

A 34-year-old woman presents to the clinic with a 2-month history of unintentional weight loss, frequent palpitations, and heat intolerance. On physical examination, her heart rate is $112/\text{min}$, and she has a fine resting tremor. Neck examination reveals a diffusely enlarged, non-tender thyroid gland. Laboratory evaluation demonstrates a thyroid-stimulating hormone (TSH) level of $0.01 \text{ }\mu\text{U/mL}$ (reference: $0.4-4.0 \text{ }\mu\text{U/mL}$) and a free thyroxine ($T_4$) level of $3.2 \text{ ng/dL}$ (reference: $0.9-1.7 \text{ ng/dL}$). She is diagnosed with Graves disease and prescribed methimazole. To understand the cellular mechanism of this patient's disease and her new medication, the physician reviews the physiological sequence of thyroid hormone synthesis. Arrange the following steps of normal thyroid hormone synthesis and release in the correct chronological order, beginning with the initial uptake of the raw material from the bloodstream.

A 66-year-old woman is evaluated in the emergency department for a 4-day history of severe, non-bloody diarrhea. She reports having up to 10 watery bowel movements daily, accompanied by diffuse abdominal cramping and a low-grade fever. She has a history of metastatic melanoma and began therapy with pembrolizumab 6 weeks ago. Her temperature is 37.8°C (100.0°F), blood pressure is 110/70 mm Hg, and pulse is 108/min. Physical examination reveals a diffusely tender abdomen with hyperactive bowel sounds, but no rebound tenderness or guarding. Laboratory studies show a serum potassium of 3.1 mEq/L and an elevated C-reactive protein. Stool PCR for *Clostridioides difficile* and routine enteric stool cultures are negative. A flexible sigmoidoscopy reveals diffuse mucosal erythema, loss of vascular pattern, and patchy ulcerations. Biopsy demonstrates a dense lymphoplasmacytic infiltrate expanding the lamina propria. In addition to intravenous fluid resuscitation, which of the following is the most appropriate targeted intervention and its corresponding immunopathologic rationale?

A hematology-oncology tumor board is reviewing molecular pathology reports for several adult patients with newly diagnosed leukemias and lymphomas. The board discusses how these specific chromosomal abnormalities dictate both the fundamental pathophysiology and the selection of targeted therapies. Match each identified cytogenetic translocation with its corresponding primary molecular consequence.

A 68-year-old woman is admitted to the hospital with a complicated intra-abdominal infection. She is started on a newly approved intravenous antimicrobial agent. The standard maintenance dose of this medication for patients with normal renal function (defined as a creatinine clearance of $100 \text{ mL/min}$) is $600 \text{ mg}$ administered every 24 hours. Pharmacokinetic data indicate that in healthy individuals, $60\%$ of the drug is eliminated unchanged in the urine, while the remaining $40\%$ undergoes hepatic metabolism. The patient's basic metabolic panel reveals an elevated serum creatinine, and her creatinine clearance is estimated to be $25 \text{ mL/min}$. Assuming linear pharmacokinetics and normal hepatic function, what should be the new daily maintenance dose in $\text{mg}$ to achieve the same steady-state average drug concentration as a patient with normal renal function?

Pair the following isolated pharmacokinetic alterations with their direct mathematical implication on therapeutic drug dosing and plasma concentration.

Match each clinical scenario of acquired antineoplastic drug resistance with the specific foundational molecular mechanism driving the neoplastic progression.

A 55-year-old man presents to the transplant clinic with a 3-day history of fatigue, dark urine, and low-grade fever. He underwent an orthotopic liver transplant 8 weeks ago for alcohol-associated cirrhosis. His current immunosuppressive regimen includes tacrolimus, mycophenolate mofetil, and prednisone. His temperature is 38.1°C (100.6°F), blood pressure is 130/80 mmHg, and heart rate is 90/min. Physical examination reveals scleral icterus and mild right upper quadrant tenderness. Laboratory tests show significantly elevated aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, and total bilirubin compared to his baseline from two weeks ago. Tacrolimus trough levels are within the target therapeutic range. The physician suspects acute cellular rejection. Arrange the following diagnostic and therapeutic steps in the most appropriate sequential order for evaluating and managing this patient's presentation.

A $24$-year-old man is hospitalized for the treatment of newly diagnosed Burkitt lymphoma. He has a massive retroperitoneal tumor burden. Yesterday, he received his first cycle of systemic combination chemotherapy. Over the past $8$ hours, his urine output has decreased to approximately $15 \text{ mL/hr}$. He reports mild nausea but denies muscle cramps, perioral numbness, or palpitations. Vital signs are stable. An electrocardiogram demonstrates a normal sinus rhythm with no PR or QT interval prolongation and normal T waves.

Laboratory evaluation reveals:
Potassium: $6.2 \text{ mEq/L}$
Uric acid: $14.8 \text{ mg/dL}$
Calcium: $6.2 \text{ mg/dL}$
Phosphorus: $9.5 \text{ mg/dL}$
Blood urea nitrogen: $45 \text{ mg/dL}$
Creatinine: $2.9 \text{ mg/dL}$ (baseline $0.9 \text{ mg/dL}$)

Based on the cellular consequences of this rapid neoplastic destruction, which of the following is the most appropriate next step in the management of this patient?

A $65$-year-old man is evaluated in the clinic for progressively worsening fatigue, constipation, and an unintended $4\text{-kg}$ ($8.8\text{-lb}$) weight gain over the past three months. His medical history is notable for ischemic cardiomyopathy and refractory atrial fibrillation, for which a new antiarrhythmic medication was initiated six months ago. Vital signs show a heart rate of $55/\text{min}$ and blood pressure of $110/70\text{ mm Hg}$. Physical examination reveals delayed relaxation of the deep tendon reflexes and dry, coarse skin. Laboratory testing shows a serum thyroid-stimulating hormone (TSH) level of $18.4\text{ mIU/L}$ (reference: $0.5-5.0\text{ mIU/L}$) and a free thyroxine (T4) level of $0.5\text{ ng/dL}$ (reference: $0.9-1.7\text{ ng/dL}$). Which of the following is the most likely primary cellular mechanism responsible for this patient's current endocrine laboratory abnormalities?

An evaluation of a $68$-year-old retired mechanic is prompted by a $3$-month history of severe, non-radiating mid-back pain and progressive fatigue. He reports no recent trauma but notes he has been increasingly constipated and urinating more frequently than usual. Vital signs are within normal limits. Physical examination reveals point tenderness over the L $3$ and L $4$ vertebrae. Laboratory investigations demonstrate a hemoglobin of $8.9 \text{ g/dL}$, serum calcium of $11.6 \text{ mg/dL}$, and serum creatinine of $2.1 \text{ mg/dL}$. A peripheral blood smear shows red blood cells stacked like coins. Serum protein electrophoresis reveals a sharp monoclonal peak in the gamma region. A subsequent skeletal survey displays multiple punched-out radiolucent lesions in the skull and lumbar spine. Which of the following best describes the primary underlying neoplastic process responsible for this patient's radiologic findings?

During a follow-up telehealth visit, a rheumatologist is evaluating a patient who was recently started on a chimeric monoclonal antibody for refractory rheumatoid arthritis. The initial infusion was administered 10 days ago without immediate complications. Today, the patient reports a 2-day history of low-grade fever, diffuse joint pain involving the wrists and ankles, and an intensely itchy rash. Photographs uploaded to the patient portal reveal widespread urticarial wheals with scattered areas of purpura. Subsequent laboratory evaluation demonstrates an elevated erythrocyte sedimentation rate and significantly reduced levels of both C3 and C4. Urinalysis shows 1+ proteinuria and 5 to 10 red blood cells per high-power field. Which of the following is the precise immunopathologic mechanism directly responsible for this patient's current clinical presentation?

Match the following clinical and laboratory profiles of disordered mineral and bone metabolism to their primary underlying molecular or cellular mechanism.

A 59-year-old woman is diagnosed with invasive ductal carcinoma of the breast following a core needle biopsy. Subsequent surgical staging reveals involvement of the ipsilateral axillary lymph nodes, indicating that local invasion and metastasis have occurred. The process of metastasis requires primary tumor cells to breach the basement membrane, traverse the interstitial connective tissue, and enter the vascular or lymphatic circulation. Arrange the following cellular and molecular steps of tumor invasion in the correct chronological order, starting with the initial event at the primary tumor site.

A 52-year-old man with stage 4 chronic kidney disease is found to have asymptomatic hypocalcemia on routine laboratory testing. To explain the pathophysiology of this finding to a medical student, the attending physician reviews the normal physiological cascade of vitamin D metabolism and its downstream effects on calcium homeostasis, highlighting the specific enzymatic step that is impaired in this patient.

Arrange the following steps of endogenous vitamin D synthesis, activation, and mechanism of action in the correct chronological order, beginning with the initial precursor in the skin.